BioCentury | Dec 13, 2017
Company News

PledPharma grants Solasia Asian rights to PledOx

PledPharma AB (SSE:PLED) granted Solasia Pharma K.K. (Tokyo:4597) exclusive rights to develop and commercialize PledOx calmangafodipir (PP100-01) in Japan, China, Hong Kong, Macau, South Korea and Taiwan in a deal valued at about ¥9.3 billion...
Items per page:
1 - 1 of 1